Barclays
ICUI icon

Barclays’s ICU Medical ICUI Stock Holding History

Barclays’s Portfolio ICUI Stock Details ICUI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,300
Closed -$2.08M – 5363
2020
Q2 		$2.08M Sell
11,300
-154,900
-93% -$30.8M ﹤0.01% 2077
2020
Q1 		$33.5M Buy
+166,200
New +$32M 0.03% 443
2019
Q3 		– Sell
-14,300
Closed -$3.6M – 6887
2019
Q2 		$3.6M Buy
+14,300
New +$3.31M ﹤0.01% 2211
2018
Q3 		– Sell
-12,100
Closed -$3.55M – 7235
2018
Q2 		$3.55M Buy
+12,100
New +$3.31M ﹤0.01% 2027

Other funds holding ICUI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's ICUI Position: Q2 2026 in Review

Barclays reduced its ICU Medical (ICUI) stake by 6.6% in Q2 2026, selling an estimated $39.9K and leaving 4,330 shares worth $635K. The position accounts for ﹤0.01% of the portfolio, ranked #3077.

Barclays first reported a position in ICUI in Q2 2013 and has held it in 51 quarters since. The position peaked at $34.5M in Q3 2021. 289 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

  • Barclays held 4,330 shares of ICU Medical worth $635K as of Q2 2026.
  • Barclays sold 306 ICU Medical shares in Q2 2026, an estimated $39.9K.
  • ICU Medical made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3077 holding.
  • Barclays first reported a position in ICU Medical in Q2 2013 and has held it in 51 quarters since.
  • Barclays's ICU Medical position peaked at $34.5M in Q3 2021.
  • 289 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.